ad
This Article
Right arrow Images Only
Right arrow Full Version
Services
Right arrow E-mail this link to a friend
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices
Right arrow Earn CME - What's This?
Related Collections
Right arrowRelated Articles

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

The first 300 words of the full text of this section appear below.

Section 3. Summaries of Infectious Diseases

Candidiasis

(Moniliasis, Thrush)

Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
Control Measures

CLINICAL MANIFESTATIONS: Mucocutaneous infection results in oral-pharyngeal (thrush) or vaginal candidiasis; intertriginous lesions of the gluteal folds, neck, groin, and axilla; paronychia; and onychia. Dysfunction of T-lymphocytes, other immunologic disorders, and endocrinologic diseases are associated with chronic mucocutaneous candidiasis. Oral candidiasis can be the presenting sign of human immunodeficiency virus (HIV) infection or primary immunodeficiency. Esophageal and laryngeal candidiasis can occur in immunocompromised patients. Disseminated or invasive candidiasis occurs in very low birth weight newborn infants and in immunocompromised or debilitated hosts, can involve virtually any organ or anatomic site, and can be rapidly fatal. Candidemia can occur with or without systemic disease in patients with indwelling vascular catheters, especially patients receiving prolonged intravenous infusions with parenteral alimentation or lipids. Candiduria can occur in patients with indwelling urinary catheters, focal renal infection, or disseminated disease.


ETIOLOGY: Candida species are yeasts that reproduce by budding. Candida albicans and some Candida tropicalis are dimorphic and form long chains of elongated yeast forms called pseudohyphae. Candida albicans causes most infections (50%–60%). Other species, including C tropicalis, Candida parapsilosis, Candida glabrata, Candida krusei, Candida guilliermondii, Candida lusitaniae, and Candida dubliniensis, also can cause serious infections in immunocompromised hosts. Candida parapsilosis is second only to C albicans as a cause of systemic candidiasis in very low birth weight neonates.


EPIDEMIOLOGY: Candida albicans is ubiquitous. Like other Candida species, C albicans is present on skin and in the mouth, intestinal tract, and vagina of immunocompetent people. Vulvovaginal candidiasis is associated with pregnancy, and newborn infants can acquire the organism in utero, during passage through the vagina, or postnatally. Mild mucocutaneous infection is common in healthy infants. Person-to-person transmission occurs rarely. Invasive . . . [Go to Full Text]


Related Articles

Echinocandins
Red Book 2006 2006: 776. [Extract] [Full Text]

Recommended Doses of Parenteral and Oral Antifungal Drugs
Red Book 2006 2006: 777-779. [Extract] [Full Text]

Drugs for Invasive and Other Serious Fungal Infections In Children
Red Book 2006 2006: 780. [Extract] [Full Text]

Topical Drugs for Superficial Fungal Infections
Red Book 2006 2006: 781-784. [Extract] [Full Text]